Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Alkermes Plc (ALKS)

Alkermes Plc (ALKS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,807,167
  • Shares Outstanding, K 161,803
  • Annual Sales, $ 1,663 M
  • Annual Income, $ 355,760 K
  • EBIT $ 447 M
  • EBITDA $ 522 M
  • 60-Month Beta 0.49
  • Price/Sales 2.92
  • Price/Cash Flow 13.20
  • Price/Book 3.75

Options Overview Details

View History
  • Implied Volatility 41.71% ( +0.55%)
  • Historical Volatility 30.10%
  • IV Percentile 75%
  • IV Rank 70.19%
  • IV High 57.70% on 10/07/24
  • IV Low 4.06% on 08/16/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 2,096
  • Volume Avg (30-Day) 224
  • Put/Call OI Ratio 0.32
  • Today's Open Interest 4,054
  • Open Int (30-Day) 3,082

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 0.77
  • Number of Estimates 5
  • High Estimate 0.89
  • Low Estimate 0.64
  • Prior Year 0.34
  • Growth Rate Est. (year over year) +126.47%

Price Performance

See More
Period Period Low Period High Performance
1-Month
27.49 +8.08%
on 11/21/24
32.25 -7.88%
on 12/09/24
+1.80 (+6.45%)
since 11/20/24
3-Month
25.67 +15.74%
on 10/31/24
32.25 -7.88%
on 12/09/24
+1.16 (+4.06%)
since 09/20/24
52-Week
22.90 +29.74%
on 07/10/24
32.88 -9.64%
on 02/16/24
+2.53 (+9.31%)
since 12/20/23

Most Recent Stories

More News
Insider Sale: EVP R&D of $ALKS (ALKS) Sells 61,151 Shares

Craig C. Hopkinson, the EVP R&D of $ALKS ($ALKS), sold 61,151 shares of the company on 12-09-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 56.2% of their...

ALKS : 29.71 (-0.87%)
Are Options Traders Betting on a Big Move in Alkermes (ALKS) Stock?

Investors in Alkermes PLC ALKS need to pay close attention to the stock based on moves in the options market lately. That is because the Dec 20, 2024 $40.00 Call had some of the highest implied volatility...

ALKS : 29.71 (-0.87%)
Alkermes' Q3 Earnings & Revenues Fall Shy of Estimates, Stock Down

Alkermes plc ALKS reported adjusted earnings from continuing operations of 73 cents per share for third-quarter 2024, which missed the Zacks Consensus Estimate of 78 cents. The company had reported adjusted...

CSTL : 27.53 (+1.62%)
ELEV : 0.5800 (-7.30%)
FATE : 1.6800 (+1.20%)
ALKS : 29.71 (-0.87%)
Alkermes: Q3 Earnings Snapshot

Alkermes: Q3 Earnings Snapshot

ALKS : 29.71 (-0.87%)
Alkermes: Q2 Earnings Snapshot

Alkermes: Q2 Earnings Snapshot

ALKS : 29.71 (-0.87%)
"Rule Breaker Investing" Stock Pick Review: The Big One

Looking back at 30 five-stock samplers picked from 2015 to 2021.

AAPL : 254.49 (+1.88%)
GOOGL : 191.41 (+1.54%)
NFLX : 909.05 (+0.78%)
AMZN : 224.92 (+0.73%)
NVDA : 134.70 (+3.08%)
TSLA : 421.06 (-3.46%)
BKNG : 5,048.59 (+1.37%)
MELI : 1,720.36 (+3.26%)
IPGP : 73.84 (-0.82%)
ALKS : 29.71 (-0.87%)
TWOU : 1.5800 (-35.25%)
GOOG : 192.96 (+1.72%)
Alkermes: Q1 Earnings Snapshot

Alkermes: Q1 Earnings Snapshot

ALKS : 29.71 (-0.87%)
Stocks Rebound as Bond Yields Fall Ahead of Wednesday’s US CPI Report

The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +0.14%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.02%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.39%. Stock indexes...

$SPX : 5,930.85 (+1.09%)
SPY : 591.15 (+1.20%)
$DOWI : 42,840.26 (+1.18%)
DIA : 428.54 (+1.24%)
$IUXX : 21,289.15 (+0.85%)
QQQ : 518.66 (+0.87%)
ZNH25 : 108-310s (+0.33%)
MRNA : 39.39 (-0.43%)
CSCO : 58.52 (+1.54%)
ON : 65.50 (+1.08%)
ADI : 211.78 (+1.93%)
GFS : 41.72 (+1.02%)
Stocks Retreat on Risk Aversion Ahead of Wednesday’s US CPI Report

The S&P 500 Index ($SPX ) (SPY ) this morning is down -0.76%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.78%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.67%. Stock indexes this...

$SPX : 5,930.85 (+1.09%)
SPY : 591.15 (+1.20%)
$DOWI : 42,840.26 (+1.18%)
DIA : 428.54 (+1.24%)
$IUXX : 21,289.15 (+0.85%)
QQQ : 518.66 (+0.87%)
ZNH25 : 108-310s (+0.33%)
NVDA : 134.70 (+3.08%)
RCL : 238.43 (+3.32%)
CCL : 26.80 (+6.43%)
NCLH : 26.91 (+5.90%)
VZ : 39.93 (-0.10%)
Stocks Mixed Before Wednesday’s US CPI Report

The S&P 500 Index ($SPX ) (SPY ) this morning is up +0.07%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.16%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.31%. Stock indexes this morning...

$SPX : 5,930.85 (+1.09%)
SPY : 591.15 (+1.20%)
$DOWI : 42,840.26 (+1.18%)
DIA : 428.54 (+1.24%)
$IUXX : 21,289.15 (+0.85%)
QQQ : 518.66 (+0.87%)
ZNH25 : 108-310s (+0.33%)
FCX : 38.86 (+1.62%)
NDAQ : 77.70 (+0.41%)
ILMN : 136.02 (+1.51%)
ON : 65.50 (+1.08%)
GFS : 41.72 (+1.02%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Alkermes plc, formed by the merger of Waltham, MA-based Alkermes, Inc. and Elan Drug Technologies (EDT), is a fully integrated global biopharmaceutical company that utilizes proprietary technologies to research, develop and commercialize, both with partners and on its own pharmaceutical products in major...

See More

Key Turning Points

3rd Resistance Point 31.05
2nd Resistance Point 30.71
1st Resistance Point 30.21
Last Price 29.71
1st Support Level 29.37
2nd Support Level 29.03
3rd Support Level 28.53

See More

52-Week High 32.88
Last Price 29.71
Fibonacci 61.8% 29.07
Fibonacci 50% 27.89
Fibonacci 38.2% 26.71
52-Week Low 22.90

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar